No doubt they could benefit kids and anyone else who has bone cancer. CycloSam is being developed by the same two people who developed Quadramet. However, my understanding from the company investor deck is that it is 40x less harmful or toxic to the body as Quadramet is. So that should be well received by the FDA. Glad you reached out to David. He seems like a good IR guy to have in our corner.
I was bid shopping to clean up the toxic paper. Paper should be gone, now we should start the rise in stock price and progress toward phase one trial! I was able to amass a large position so I will be a hero or a zero time will tell....
News 
Market Data 
Discover 
